Nardil Response in a Chronic Obsessive Compulsive

No abstract is available for this paper.

• Publication year

  1969

• Venue

  British Journal of Psychiatry

• Publication date

  1969-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1192/BJP.115.523.748PMID 5806868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Iproniazid in Depressive Syndromes

  1959cited by this paper

• Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder?

  2021cites this paper
• Monoamine Oxidase Inhibitors for Various Psychiatric Disorders and Conditions

  2014cites this paper
• [Phenelzine: legacy or current psychiatric practice?].

  2013cites this paper
• A review of pharmacologic treatments for obsessive-compulsive disorder.

  2003cites this paper
• 114 CURRENT AND EXPERIMENTAL THERAPEUTICS OF OCD

  2002cites this paper
• Pharmacotherapy for obsessive-compulsive disorder.

  2000cites this paper
• [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].

  1993cites this paper
• Treatment of the neuroses.

  1992cites this paper
• Pharmacologic treatment of obsessive compulsive disorders.

  1992cites this paper
• The Pharmacological Treatment of Obsessive-Compulsive Disorders

  1990cites this paper
• Tranylcypromine in primary obsessive-compulsive disorder

  1990cites this paper
• Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?

  1990cites this paper
• Pharmacotherapy of Obsessive‐Compulsive Disorder

  1990cites this paper
• Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research.

  1988cites this paper
• The Involvement of Serotonin in Psychiatric Disorders and Behaviour

  1988cites this paper
• The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.

  1988cites this paper
• Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.

  1987cites this paper
• The use of psychopharmacology in obsessive compulsive disorders.

  1987cites this paper
• Monoamine oxidase inhibitors: have they a place, have they a future?

  1987cites this paper
• Somatic treatments for obsessive-compulsive disorders.

  1987cites this paper
• Drug treatment of obsessive-compulsive disorder.

  1987cites this paper
• Clinical pharmacology of monoamine oxidase inhibitors.

  1986cites this paper
• Obsessive-compulsive disorder successfully treated with trazodone.

  1986cites this paper
• Pharmacotherapy of Obsessive-Compulsive Disorder

  1985cites this paper
• Obsessive-compulsive disorder.

  1985cites this paper
• Alprazolam in the treatment of obsessive symptoms.

  1985cites this paper
• Evidence for a biological hypothesis of obsessive-compulsive disorder.

  1984cites this paper
• Monoamine oxidase inhibitors in obsessive-compulsive disorder.

  1983cites this paper
• Obsessive compulsive disorder.

  1983cites this paper
• Psychopharmakotherapie bei Angstsyndromen, phobischen Syndromen und Zwangssyndromen

  1983cites this paper
• Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.

  1983cites this paper
• Chapter 9 – Monoamine oxidase inhibitors and amine precursors

  1982cites this paper
• Maoi for Obsessive Compulsive Disorder

  1982cites this paper
• Obsessive-compulsive disorders: a review of the literature.

  1981cites this paper
• A comparison of phenelzine and imipramine in an obsessive-compulsive patient.

  1981cites this paper
• Rapid response of severe obsessive-compulsive disorder to tranylcypromine.

  1981cites this paper
• Obsessive-compulsive disorder of childhood and adolescence. A neurobiological viewpoint.

  1980cites this paper
• Obsessive–compulsives: Conceptual Issues and Treatment Interventions

  1979cites this paper
• Treatment of obsessive compulsive neurosis: pharmacological approach.

  1976cites this paper
• The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.

  1973cites this paper
• Concurrence of Turner's Syndrome and Anorexia Nervosa

  1970cites this paper
• Phenelzine in obsessional neurosis.

  1970cites this paper